Stock 688393 GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Guangzhou LBP Medicine Science & Technology Co., Ltd.

Equities

688393

CNE1000043R4

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
17 CNY +1.61% Intraday chart for Guangzhou LBP Medicine Science & Technology Co., Ltd. +10.39% -31.92%
Apr. 23 LBP Medicine Scraps Convertible Bonds Issuance Plans MT
Apr. 19 LBP Medicine Gets Certificate for HER2 Antibody Reagent MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LBP Medicine Scraps Convertible Bonds Issuance Plans
MT
LBP Medicine Gets Certificate for HER2 Antibody Reagent
MT
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Certain A Shares of LBP Medicine Science & Technology Co., Ltd are subject to a Lock-Up Agreement Ending on 20-AUG-2023.
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it expects to receive CNY 20 million in funding from Guangzhou LBP Medicine Science & Technology Co., Ltd., Guangzhou Anbiping No. 1 Investment Partnership Enterprise (Limited Partnership), Guangzhou Anbiping No. 2 Investment Partnership Enterprise (Limited Partnership)
CI
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd.(SHSE:688393) added to Shanghai Stock Exchange Composite Index
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd.(SHSE:688393) added to Shanghai Stock Exchange A Share Index
CI
Certain A Shares of LBP Medicine Science & Technology Co., Ltd are subject to a Lock-Up Agreement Ending on 20-AUG-2021.
CI
Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688393 Stock
  4. News Guangzhou LBP Medicine Science & Technology Co., Ltd.